Overview

Effects of Nebivolol on Subclinical Left Ventricular dySfunction: A Comparative Study Against Metoprolol

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
Summary: - Study title: Effects of Nebivolol on subclinical left ventricular dysfunction. A comparative study against Metoprolol. (ENESYS study) - Study phase: 3 - Study design (parallel, cross-over, etc.), randomisation and blinding procedures, type of control (placebo or active): randomised, parallel, active-controlled, open label - Study treatment(s)/drug(s): Nebivolol versus Metoprolol - Patients: - characteristics: patients with hypertension and left ventricular hypertrophy - planned total number: 50 - Study duration: - total enrolment period (months): 18 - treatment period (months): 6 - follow up period (months): 6 - Total study duration (months): 24 - Number of Centres: 1 - Country(ies): Romania (RO)
Phase:
Phase 3
Details
Lead Sponsor:
Berlin-Chemie Menarini
Treatments:
Metoprolol
Nebivolol